Where Will Asana Stock Be in 5 Years?
Asana stock hasn’t given many investors on Wall Street any…
Sell
28
HBIO Quote, Financials, Valuation and Earnings
Last price:
$0.44
Seasonality move
:
1.38%
Day range:
$0.43 - $0.58
52-week range:
$0.28 - $3.60
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.22x
P/B ratio:
1.39x
Volume:
13.6M
Avg. volume:
22.5M
1-year change:
-85.03%
Market cap:
$20.6M
Revenue:
$94.1M
EPS (TTM):
-$1.32
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $102.1M | $118.9M | $113.3M | $112.3M | $94.1M | |
| Revenue Growth (YoY) | -12.12% | 16.46% | -4.68% | -0.96% | -16.14% | |
| Cost of Revenues | $44.1M | $51.3M | $52.5M | $46.2M | $39.4M | |
| Gross Profit | $58M | $67.7M | $60.8M | $66.1M | $54.8M | |
| Gross Profit Margin | 56.85% | 56.9% | 53.66% | 58.86% | 58.18% | |
| R&D Expenses | $8.7M | $10.8M | $12.3M | $11.8M | $10.4M | |
| Selling, General & Admin | $43.4M | $48.9M | $49.5M | $46.8M | $43.7M | |
| Other Inc / (Exp) | -$2.7M | -$666K | $535K | -$859K | -$2.2M | |
| Operating Expenses | $57.8M | $65.6M | $68M | $64.2M | $61M | |
| Operating Income | $221K | $2.1M | -$7.2M | $1.9M | -$6.2M | |
| Net Interest Expenses | $4.8M | $1.5M | $2.5M | $3.6M | $3.2M | |
| EBT. Incl. Unusual Items | -$7.3M | -$140K | -$9.2M | -$2.6M | -$11.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $518K | $148K | $337K | $859K | $740K | |
| Net Income to Company | -$7.8M | -$288K | -$9.5M | -$3.4M | -$12.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$7.8M | -$288K | -$9.5M | -$3.4M | -$12.4M | |
| Basic EPS (Cont. Ops) | -$0.20 | -$0.01 | -$0.23 | -$0.08 | -$0.28 | |
| Diluted EPS (Cont. Ops) | -$0.20 | -$0.01 | -$0.23 | -$0.08 | -$0.28 | |
| Weighted Average Basic Share | $38.6M | $40.3M | $41.4M | $42.4M | $43.5M | |
| Weighted Average Diluted Share | $38.6M | $40.3M | $41.4M | $42.4M | $43.5M | |
| EBITDA | $5.2M | $9M | $944K | $8M | -$1.3M | |
| EBIT | -$2.5M | $1.4M | -$6.6M | $1M | -$8.5M | |
| Revenue (Reported) | $102.1M | $118.9M | $113.3M | $112.3M | $94.1M | |
| Operating Income (Reported) | $221K | $2.1M | -$7.2M | $1.9M | -$6.2M | |
| Operating Income (Adjusted) | -$2.5M | $1.4M | -$6.6M | $1M | -$8.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $27M | $28.8M | $30M | $24.5M | $21.8M | |
| Revenue Growth (YoY) | 13.54% | 6.63% | 4.16% | -18.23% | -11.17% | |
| Cost of Revenues | $11.6M | $12.6M | $11.6M | $9.7M | $9.6M | |
| Gross Profit | $15.4M | $16.2M | $18.3M | $14.8M | $12.2M | |
| Gross Profit Margin | 57.18% | 56.21% | 61.2% | 60.26% | 55.96% | |
| R&D Expenses | $2.5M | $3.2M | $2.9M | $2.9M | $2.3M | |
| Selling, General & Admin | $11.7M | $13M | $12.3M | $11.9M | $10.2M | |
| Other Inc / (Exp) | -$34K | -$5.1M | $432K | -$2.4M | -$48.5M | |
| Operating Expenses | $15.7M | $17.7M | $16.6M | $16.1M | $13.6M | |
| Operating Income | -$239K | -$1.5M | $1.7M | -$1.3M | -$1.5M | |
| Net Interest Expenses | $411K | $384K | $974K | $751K | $802K | |
| EBT. Incl. Unusual Items | -$684K | -$7M | $1.2M | -$4.5M | -$50.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$15K | -$138K | $585K | $210K | -$454K | |
| Net Income to Company | -$669K | -$6.9M | $622K | -$4.7M | -$50.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$669K | -$6.9M | $622K | -$4.7M | -$50.3M | |
| Basic EPS (Cont. Ops) | -$0.02 | -$0.17 | $0.01 | -$0.11 | -$1.14 | |
| Diluted EPS (Cont. Ops) | -$0.02 | -$0.17 | $0.01 | -$0.11 | -$1.14 | |
| Weighted Average Basic Share | $39.8M | $41.2M | $42.1M | $43.4M | $44.1M | |
| Weighted Average Diluted Share | $39.8M | $41.2M | $42.8M | $43.4M | $44.1M | |
| EBITDA | $1.6M | -$4.8M | $3.9M | -$2M | -$48.3M | |
| EBIT | -$273K | -$6.6M | $2.2M | -$3.7M | -$50M | |
| Revenue (Reported) | $27M | $28.8M | $30M | $24.5M | $21.8M | |
| Operating Income (Reported) | -$239K | -$1.5M | $1.7M | -$1.3M | -$1.5M | |
| Operating Income (Adjusted) | -$273K | -$6.6M | $2.2M | -$3.7M | -$50M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $105.3M | $120.7M | $114.5M | $106.8M | $91.4M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $44.8M | $52.3M | $51.5M | $44.3M | $39.2M | |
| Gross Profit | $60.5M | $68.4M | $63M | $62.5M | $52.2M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $8.7M | $11.5M | $12M | $11.8M | $9.8M | |
| Selling, General & Admin | $42.8M | $50.2M | $48.8M | $46.4M | $42M | |
| Other Inc / (Exp) | -$2.8M | -$5.7M | $6.1M | -$3.7M | -$48.4M | |
| Operating Expenses | $57.2M | $67.6M | $66.9M | $63.7M | $58.5M | |
| Operating Income | $3.3M | $784K | -$3.9M | -$1.2M | -$6.4M | |
| Net Interest Expenses | $3.9M | $1.5M | $3.1M | $3.4M | $3.3M | |
| EBT. Incl. Unusual Items | -$3.5M | -$6.5M | -$954K | -$8.2M | -$58M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $448K | $25K | $1.1M | $484K | $76K | |
| Net Income to Company | -$4M | -$6.5M | -$2M | -$8.7M | -$58.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$4M | -$6.5M | -$2M | -$8.7M | -$58.1M | |
| Basic EPS (Cont. Ops) | -$0.11 | -$0.16 | -$0.05 | -$0.20 | -$1.32 | |
| Diluted EPS (Cont. Ops) | -$0.11 | -$0.16 | -$0.05 | -$0.20 | -$1.32 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $8.1M | $2.6M | $9.6M | $2.2M | -$47.7M | |
| EBIT | $428K | -$5M | $2.2M | -$4.9M | -$54.7M | |
| Revenue (Reported) | $105.3M | $120.7M | $114.5M | $106.8M | $91.4M | |
| Operating Income (Reported) | $3.3M | $784K | -$3.9M | -$1.2M | -$6.4M | |
| Operating Income (Adjusted) | $428K | -$5M | $2.2M | -$4.9M | -$54.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $27M | $28.8M | $30M | $24.5M | $21.8M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $11.6M | $12.6M | $11.6M | $9.7M | $9.6M | |
| Gross Profit | $15.4M | $16.2M | $18.3M | $14.8M | $12.2M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $2.5M | $3.2M | $2.9M | $2.9M | $2.3M | |
| Selling, General & Admin | $11.7M | $13M | $12.3M | $11.9M | $10.2M | |
| Other Inc / (Exp) | -$34K | -$5.1M | $432K | -$2.4M | -$48.5M | |
| Operating Expenses | $15.7M | $17.7M | $16.6M | $16.1M | $13.6M | |
| Operating Income | -$239K | -$1.5M | $1.7M | -$1.3M | -$1.5M | |
| Net Interest Expenses | $411K | $384K | $974K | $751K | $802K | |
| EBT. Incl. Unusual Items | -$684K | -$7M | $1.2M | -$4.5M | -$50.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$15K | -$138K | $585K | $210K | -$454K | |
| Net Income to Company | -$669K | -$6.9M | $622K | -$4.7M | -$50.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$669K | -$6.9M | $622K | -$4.7M | -$50.3M | |
| Basic EPS (Cont. Ops) | -$0.02 | -$0.17 | $0.01 | -$0.11 | -$1.14 | |
| Diluted EPS (Cont. Ops) | -$0.02 | -$0.17 | $0.01 | -$0.11 | -$1.14 | |
| Weighted Average Basic Share | $39.8M | $41.2M | $42.1M | $43.4M | $44.1M | |
| Weighted Average Diluted Share | $39.8M | $41.2M | $42.8M | $43.4M | $44.1M | |
| EBITDA | $1.6M | -$4.8M | $3.9M | -$2M | -$48.3M | |
| EBIT | -$273K | -$6.6M | $2.2M | -$3.7M | -$50M | |
| Revenue (Reported) | $27M | $28.8M | $30M | $24.5M | $21.8M | |
| Operating Income (Reported) | -$239K | -$1.5M | $1.7M | -$1.3M | -$1.5M | |
| Operating Income (Adjusted) | -$273K | -$6.6M | $2.2M | -$3.7M | -$50M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $8.3M | $7.8M | $4.5M | $4.3M | $4.1M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $17.8M | $21.8M | $16.7M | $16.1M | $14.9M | |
| Inventory | $22.3M | $27.6M | $26.4M | $24.7M | $23.2M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $3.4M | $4.3M | $3.5M | $3.9M | $2.9M | |
| Total Current Assets | $51.7M | $61.6M | $51.1M | $49M | $45.1M | |
| Property Plant And Equipment | $11.7M | $10.3M | $9.2M | $8.8M | $11.2M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $58.6M | $57.7M | $56.3M | $57.1M | $56.3M | |
| Other Intangibles | $33.2M | $27.4M | $21M | $16M | $11.1M | |
| Other Long-Term Assets | $1.1M | $5.4M | $7.8M | $6.5M | $2.8M | |
| Total Assets | $156.3M | $162.3M | $145.4M | $137.4M | $126.6M | |
| Accounts Payable | $6M | $4.9M | $6.4M | $5.6M | $4.8M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $1.7M | $3.2M | $3.8M | $5.9M | $37M | |
| Current Portion Of Capital Lease Obligations | $2.1M | $2.1M | $2.1M | $1.4M | $1.2M | |
| Other Current Liabilities | $3.3M | $4.3M | $4M | $5.3M | $6.5M | |
| Total Current Liabilities | $21.1M | $25.3M | $23.2M | $26.5M | $55M | |
| Long-Term Debt | $46.3M | $45.1M | $43M | $30.7M | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $79.6M | $78.9M | $73.1M | $64.3M | $63.3M | |
| Common Stock | $444K | $452K | $454K | $434K | $441K | |
| Other Common Equity Adj | -$13.1M | -$10M | -$15.1M | -$14.2M | -$15.7M | |
| Common Equity | $76.7M | $83.4M | $72.2M | $73.1M | $63.3M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $76.7M | $83.4M | $72.2M | $73.1M | $63.3M | |
| Total Liabilities and Equity | $156.3M | $162.3M | $145.4M | $137.4M | $126.6M | |
| Cash and Short Terms | $8.3M | $7.8M | $4.5M | $4.3M | $4.1M | |
| Total Debt | $48M | $48.3M | $46.8M | $36.6M | $37M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $5.8M | $5.4M | $3.8M | $4.3M | $5.5M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $17.1M | $20.3M | $17.7M | $15.3M | $13.5M | |
| Inventory | $22.7M | $28.7M | $26.9M | $24.1M | $22.8M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $3.7M | $5M | $4.1M | $4.4M | $3.1M | |
| Total Current Assets | $49.2M | $59.4M | $52.4M | $48.1M | $44.9M | |
| Property Plant And Equipment | $11.1M | $10.1M | $8.9M | $8.9M | $12.3M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $58.2M | $57.4M | $56.6M | $56.7M | $9M | |
| Other Intangibles | $31.9M | $25.9M | $19.6M | $14.7M | $10.1M | |
| Other Long-Term Assets | $812K | $5.3M | $7.9M | $4.8M | $3.5M | |
| Total Assets | $151.2M | $158M | $145.6M | $133.2M | $79.8M | |
| Accounts Payable | $6.4M | $6.2M | $6M | $6M | $4.8M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $2M | $2.7M | $3M | $3.7M | $36M | |
| Current Portion Of Capital Lease Obligations | $2.1M | $2.2M | $2.1M | $1.2M | $1.4M | |
| Other Current Liabilities | $3.6M | $8.9M | $3.9M | $7.1M | $8.1M | |
| Total Current Liabilities | $20.7M | $27.2M | $23.2M | $25.7M | $55.6M | |
| Long-Term Debt | $41.6M | $46.2M | $41.1M | $31.9M | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $74.1M | $81.7M | $71.2M | $64.3M | $65M | |
| Common Stock | $448K | $452K | $455K | $434K | $442K | |
| Other Common Equity Adj | -$14.4M | -$10.7M | -$14.7M | -$14.8M | -$14.4M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $77.1M | $76.4M | $74.3M | $68.8M | $14.8M | |
| Total Liabilities and Equity | $151.2M | $158M | $145.6M | $133.2M | $79.8M | |
| Cash and Short Terms | $5.8M | $5.4M | $3.8M | $4.3M | $5.5M | |
| Total Debt | $43.6M | $49M | $44.1M | $35.6M | $36M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$7.8M | -$288K | -$9.5M | -$3.4M | -$12.4M | |
| Depreciation & Amoritzation | $7.6M | $7.6M | $7.6M | $7M | $7.2M | |
| Stock-Based Compensation | $3.6M | $4.2M | $4.4M | $5M | $4.3M | |
| Change in Accounts Receivable | $3.1M | -$4.3M | $4.8M | $810K | $974K | |
| Change in Inventories | $413K | -$5.9M | $252K | $1.5M | -$64K | |
| Cash From Operations | $9.3M | $1.3M | $1.2M | $14M | $1.4M | |
| Capital Expenditures | $1.4M | $1.3M | $1.6M | $2.3M | $3.3M | |
| Cash Acquisitions | -- | -- | -- | $512K | -- | |
| Cash From Investing | -$1.4M | -$1.3M | -$1.6M | -$1.8M | -$1.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $61.3M | $4.3M | $7.8M | $4.5M | $8.8M | |
| Long-Term Debt Repaid | -$66.9M | -$4.2M | -$9.6M | -$15M | -$8.6M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$3M | -$3.6M | -$1.6M | -$2.5M | -$738K | |
| Cash From Financing | -$8M | -$252K | -$2.8M | -$12.1M | -$131K | |
| Beginning Cash (CF) | $8.3M | $8.3M | $7.8M | $4.5M | $4.3M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$38K | -$335K | -$3.3M | $95K | -$35K | |
| Ending Cash (CF) | $8.3M | $7.8M | $4.5M | $4.3M | $4.1M | |
| Levered Free Cash Flow | $7.9M | -$83K | -$438K | $11.7M | -$1.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$669K | -$6.9M | $622K | -$4.7M | -$50.3M | |
| Depreciation & Amoritzation | $1.9M | $1.8M | $1.7M | $1.8M | $1.7M | |
| Stock-Based Compensation | $968K | $1M | $1.2M | $1M | $600K | |
| Change in Accounts Receivable | $584K | $1.5M | -$923K | $704K | $1.4M | |
| Change in Inventories | -$602K | -$1.3M | -$292K | -$617K | $670K | |
| Cash From Operations | $1M | -$2M | $1.8M | $1.4M | $3M | |
| Capital Expenditures | $301K | $471K | $224K | $720K | $683K | |
| Cash Acquisitions | -- | -- | $512K | -- | -- | |
| Cash From Investing | -$301K | -$471K | $288K | -$225K | -$683K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $1.5M | $1.5M | $2.5M | -- | |
| Long-Term Debt Repaid | -$4.5M | -$936K | -$4.3M | -$3.5M | -$1M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$565K | -$501K | -$156K | -$47K | -$204K | |
| Cash From Financing | -$3.1M | $94K | -$2.9M | -$1.1M | -$1.2M | |
| Beginning Cash (CF) | $8.3M | $7.8M | $4.5M | $4.3M | $4.1M | |
| Foreign Exchange Rate Adjustment | -$97K | -$25K | $74K | -$151K | $339K | |
| Additions / Reductions | -$2.4M | -$2.4M | -$793K | $123K | $1.1M | |
| Ending Cash (CF) | $5.8M | $5.4M | $3.8M | $4.3M | $5.5M | |
| Levered Free Cash Flow | $736K | -$2.5M | $1.6M | $683K | $2.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$4M | -$6.5M | -$2M | -$8.7M | -$58.1M | |
| Depreciation & Amoritzation | $7.6M | $7.6M | $7.4M | $7.1M | $7M | |
| Stock-Based Compensation | $3.8M | $4.2M | $4.5M | $4.9M | $3.9M | |
| Change in Accounts Receivable | -$1.5M | -$3.4M | $2.4M | $2.4M | $1.7M | |
| Change in Inventories | $1.2M | -$6.6M | $1.3M | $1.2M | $1.2M | |
| Cash From Operations | $7.5M | -$1.8M | $5M | $13.6M | $3M | |
| Capital Expenditures | $1.5M | $1.5M | $1.3M | $2.8M | $3.2M | |
| Cash Acquisitions | -- | -- | $512K | -- | -- | |
| Cash From Investing | -$1.5M | -$1.5M | -$831K | -$2.3M | -$1.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $61.3M | $5.8M | $7.8M | $5.5M | $6.3M | |
| Long-Term Debt Repaid | -$66.6M | -$636K | -$13M | -$14.2M | -$6.1M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$3.4M | -$3.6M | -$1.3M | -$2.4M | -$895K | |
| Cash From Financing | -$6M | $3M | -$5.8M | -$10.3M | -$280K | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$2K | -$293K | -$1.7M | $1M | $941K | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $6M | -$3.3M | $3.6M | $10.8M | -$203K | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$669K | -$6.9M | $622K | -$4.7M | -$50.3M | |
| Depreciation & Amoritzation | $1.9M | $1.8M | $1.7M | $1.8M | $1.7M | |
| Stock-Based Compensation | $968K | $1M | $1.2M | $1M | $600K | |
| Change in Accounts Receivable | $584K | $1.5M | -$923K | $704K | $1.4M | |
| Change in Inventories | -$602K | -$1.3M | -$292K | -$617K | $670K | |
| Cash From Operations | $1M | -$2M | $1.8M | $1.4M | $3M | |
| Capital Expenditures | $301K | $471K | $224K | $720K | $683K | |
| Cash Acquisitions | -- | -- | $512K | -- | -- | |
| Cash From Investing | -$301K | -$471K | $288K | -$225K | -$683K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $1.5M | $1.5M | $2.5M | -- | |
| Long-Term Debt Repaid | -$4.5M | -$936K | -$4.3M | -$3.5M | -$1M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$565K | -$501K | -$156K | -$47K | -$204K | |
| Cash From Financing | -$3.1M | $94K | -$2.9M | -$1.1M | -$1.2M | |
| Beginning Cash (CF) | $8.3M | $7.8M | $4.5M | $4.3M | $4.1M | |
| Foreign Exchange Rate Adjustment | -$97K | -$25K | $74K | -$151K | $339K | |
| Additions / Reductions | -$2.4M | -$2.4M | -$793K | $123K | $1.1M | |
| Ending Cash (CF) | $5.8M | $5.4M | $3.8M | $4.3M | $5.5M | |
| Levered Free Cash Flow | $736K | -$2.5M | $1.6M | $683K | $2.3M | |
Get HBIO Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
HBIO
Sector
P/E ratio
--
24.27x
PEG ratio
0.00x
0.00x
P/B ratio
1.39x
1.75x
Price / LTM sales
0.22x
1.65x
Growth Metrics
HBIO
Sector
Revenue growth
-11.17%
4.98%
Earnings growth
--
7.49%
Revenue (5-year growth)
-4.12%
8.25%
Earnings forecast
-$0.04
-$0.20
Profitability
HBIO
Sector
Profitability FY 2024
$54.8M
$51.2M
Return on invested capital
-62.88%
-14.95%
Return on assets
-48.4%
-12.07%
Return on equity
-103.83%
-17.16%
Earnings Date
Last Earnings Date
May
12
Next Earnings Date
Aug
8
Estimated Next Earnings Date
Aug
11
Balance Sheet
HBIO
Sector
Total cash
$5.5M
$38.3M
Short term investments
--
$32.2M
Total assets
$126.6M
$118.2M
Long term debt
$36M
$8.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Dell Stock Be in 5 Years?
So you’re looking at Dell (NASDAQ: DELL) and wondering, “Is…
Where Will Cameco Stock Be in 5 Years?
Cameco (NYSE: CCJ) isn’t exactly the kind of stock you…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
82
SBET alert for May 31
SharpLink Gaming [SBET] is down 3.17% over the past day.
Buy
55
RGC alert for May 31
Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.
Buy
56
SVT alert for May 31
Servotronics [SVT] is up 0.17% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
